# The Prevention Options for Women Evaluation Research (POWER) Cohort

> **NCT03490058** · — · COMPLETED · sponsor: **University of Washington** · enrollment: 2255 (actual)

## Conditions studied

- HIV/AIDS

## Interventions

- **DRUG:** Truvada

## Key facts

- **NCT ID:** NCT03490058
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-14
- **Primary completion:** 2020-12-04
- **Final completion:** 2021-07-23
- **Target enrollment:** 2255 (ACTUAL)
- **Last updated:** 2021-12-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03490058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03490058, "The Prevention Options for Women Evaluation Research (POWER) Cohort". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03490058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*